Is GALT or GHRS more undervalued in 2026?

CirclFi compares Galectin Therapeutics Inc. (GALT) and GH Research PLC (GHRS) using 13 institutional-grade valuation models. GALT has a Quality of Company score of 3.7/10 while GHRS scores 4.4/10.

Which is a better buy — GALT or GHRS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GALT and GHRS valuations compare?

GALT at $2.57 and GHRS at $22.38 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GALT vs GHRS Valuation Comparison 2026 — Intrinsic Value Analysis

GALT

Biotechnology

Galectin Therapeutics Inc.

Quality

3.7

out of 10

Value Trap

SAFE

Price

$2.57

Last close

Models

6/13

Active

GHRS

Biotechnology

GH Research PLC

Quality

4.4

out of 10

Value Trap

SAFE

Price

$22.38

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	GALT Fair Value	GALT Upside	GHRS Fair Value	GHRS Upside
Bayesian DCF	Intrinsic	$0.80	-68.8%	$3.69	-83.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$2.62	-88.3%
PWERM	Option-Based	$4.46	+73.5%	$20.86	-6.8%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GALT vs GHRS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GALT vs GHRS — Which Stock Is More Undervalued?

GHRS scores higher with a 4.4/10 quality rating vs GALT's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Galectin Therapeutics Inc. (GALT) and GH Research PLC (GHRS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GALT currently trades at $2.57 with a QOC of 3.7/10, while GHRS trades at $22.38 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).